Key statistics
On Friday, Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) closed at 1,795.30, -8.42% below its 52-week high of 1,960.35, set on Sep 30, 2024.
52-week range
Open | 1,785.00 |
---|---|
High | 1,814.95 |
Low | 1,768.05 |
Bid | 1,795.30 |
Offer | 1,807.40 |
Previous close | 1,770.80 |
Average volume | 1.76m |
---|---|
Shares outstanding | 2.40bn |
Free float | 1.08bn |
P/E (TTM) | 38.59 |
Market cap | 4.27tn INR |
EPS (TTM) | 46.12 INR |
Annual div (ADY) | 13.50 INR |
---|---|
Annual div yield (ADY) | 0.76% |
Div ex-date | Jul 12 2024 |
Div pay-date | Aug 16 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 10:27 GMT.
More ▼
- Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
- Studies Show Sun Pharma's WINLEVI® (clascoterone) Cream 1% Reduces Sebum Levels and is Suitable for Combination With Other Commonly Used Topical Acne Medications
- Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology Conference
- Sun Pharma Presents New Clinical Efficacy and Safety Data in Severe Dermatological Conditions at the 2024 European Academy of Dermatology and Venereology (EADV) Congress